IL-10 and IL-10 receptor defects in humans

被引：193

作者：

Glocker, Erik-Oliver ^{[1
]}

Kotlarz, Daniel ^{[2
]}

Klein, Christoph ^{[2
]}

Shah, Neil ^{[3
]}

Grimbacher, Bodo ^{[4
,5
]}

机构：

[1] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany

[2] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany

[3] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London, England

[4] UCL, Sch Med, Dept Immunol, London W1N 8AA, England

[5] Univ Hosp Freiburg, Ctr Chron Immune Deficiency, Freiburg, Germany

来源：

YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II | 2011年 / 1246卷

关键词：

IL-10; receptor; mutation; STAT3; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; X-LINKED SYNDROME; INTERLEUKIN-10; RECEPTOR; IMMUNE DYSREGULATION; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; HOST-DEFENSE; POLYENDOCRINOPATHY;

D O I：

10.1111/j.1749-6632.2011.06339.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is chronic in nature and is characterized by abdominal pain, diarrhea, bleeding, and malabsorption. It is considered a complex multigenic and multifactorial disorder that results from disturbed interactions between the immune system and commensal bacteria of the gut. Recent work has demonstrated that IBD with an early-onset within the first months of life can be monogenic: mutations in IL-10 or its receptor lead to a loss of IL-10 function and cause severe intractable enterocolitis in infants and small children. Both IL-10 and IL-10 receptor deficiency can be successfully treated by hematopoietic stem cell transplantation.

引用

页码：102 / 107

页数：6

共 50 条

[41] A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease
van der Linde, K
Boor, PPC
Sandkuijl, LA
Meijssen, MAC
Savelkoul, HFJ
Wilson, JHP
de Rooij, FWM
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) : 611 - 617
[42] The Genetics of Crohn's Disease
Van Limbergen, Johan
Wilson, David C.
Satsangi, Jack
[J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2009, 10 : 89 - 116
[43] Interleukin-10 suppression of myeloid cell activation - a continuing puzzle
Williams, LM
Ricchetti, G
Sarma, U
Smallie, T
Foxwell, BMJ
[J]. IMMUNOLOGY, 2004, 113 (03) : 281 - 292
[44] IL-22 increases the innate immunity of tissues
Wolk, K
Kunz, S
Witte, E
Friedrich, M
Asadullah, K
Sabat, R
[J]. IMMUNITY, 2004, 21 (02) : 241 - 254
[45] Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells
Wolk, Kerstin
Sabat, Robert
[J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (05) : 367 - 380
[46] IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes:: a potential role in psoriasis
Wolk, Kerstin
Witte, Ellen
Wallace, Elizabeth
Doecke, Wolf-Dietrich
Kunz, Stefanie
Asadullah, Khusru
Volk, Hans-Dieter
Sterry, Wolfram
Sabat, Robert
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (05) : 1309 - 1323
[47] Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J.
Podolsky, D. K.
[J]. NATURE, 2007, 448 (7152) : 427 - 434
[48] Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Zenewicz, Lauren A.
Yancopoulos, George D.
Valenzuela, David M.
Murphy, Andrew J.
Stevens, Sean
Flavell, Richard A.
[J]. IMMUNITY, 2008, 29 (06) : 947 - 957
[49] Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Yan
Valdez, Patricia A.
Danilenko, Dimitry M.
Hu, Yan
Sa, Susan M.
Gong, Qian
Abbas, Alexander R.
Modrusan, Zora
Ghilardi, Nico
de Sauvage, Frederic J.
Ouyang, Wenjun
[J]. NATURE MEDICINE, 2008, 14 (03) : 282 - 289
[50] FOXP3: Of mice and men
Ziegler, Steven F.
[J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 209 - 226

← 1 2 3 4 5 →